MSD under CMA investigation over unfair Remicade pricing
May 24, 2017Research and Development, Sales and Marketing Competition and Marketing Authority, MSD, Remicade
MSD is facing legal trouble after the Competition and Marketing Authority (CMA) alleged that the pharmaceutical firm had engaged in …
Opioid crisis “highest initial priority” for new FDA Commissioner
May 24, 2017Medical Communications, Research and Development FDA, Scott Gottlieb, opioid, opioid crisis
Scott Gottlieb, the newly appointment FDA Commissioner, has indicated that his first priority is to tackle the opioid crisis currently …
The June 2017 issue of Pharmafocus is now live!
May 23, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Pharmafocus, Roche, Takeda, UK, brexit, data management, market access, neurological disorders
The latest edition of Pharmafocus is available to read online now!
European approval for novel Eisai epilepsy monotherapy
May 23, 2017Research and Development, Sales and Marketing Bial, Eisai, Zebinix, epilepsy
Eisai and Bial have revealed that their drug Zebinix (eslicarbazepine acetate) has been awarded marketing authorisation by the European Commission …
Nativis Incorporated appoints new CSO
May 23, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Nativis
Nativis, a clinical stage life science bio-clectronic company, has appointed Dr Kenneth Ferguson to the position of Chief Scientific Officer. …
Shortage of medicine made of kitchen basics hits US
May 23, 2017Manufacturing and Production Pfizer, Sodium bicarbonate
Do you have a pot of unused baking soda that sits at the back of the cupboard, forgotten? Well, hospitals …
Strong showing for AZ asthma drug, but diabetes treatment flops
May 23, 2017Manufacturing and Production, Research and Development AstraZeneca, asthma, diabetes
AstraZeneca has been mulling over mixed news this week after both its severe asthma treatment and diabetes therapy saw varying …
U-turn performed over Conservative’s social care plans
May 23, 2017Manufacturing and Production, Medical Communications Conservative, Dementia tax, Election 2017, Jeremy Corbyn, Labour, Theresa May
One of the most controversial points of the Conservative’s was its social care plan. The plan would have seen those …
Sanofi and Regeneron score FDA approval for arthritis
May 23, 2017Manufacturing and Production, Sales and Marketing FDA, Kevzara, arthritis, sarilumab
The FDA has awarded Sanofi and Regeneron’s Kevzara (sarilumab) approval for the treatment of moderate to severely active rheumatoid arthritis …
EMA’s CHMP recommends Sanofi’s Humalog biosimilar
May 22, 2017Manufacturing and Production, Sales and Marketing Eli Lilly, Humalog, Sanofi
Sanofi has received a positive recommendation by the CHMP for its biosimilar to Eli Lilly’s Humalog. The recommendation for approval …
J&J lines up its Global Head for Actelion
May 22, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Actelion, Janssen, Johnson & Johnson
The deal is not yet complete but the last steps are assumed to be a formality – at least Johnson …
Behind the NHS recruitment crisis
May 22, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NHS, NHS Providers
NHS Providers, the membership organisation and trade association for the NHS, laid a stark warning at the door of the …
Sanofi Zika vaccine deal causes controversy
May 22, 2017Sales and Marketing Sanofi, US army, Zika
In a further twist to Sanofi’s deal with the US Army to develop a vaccine for the Zika virus, the …
Novartis cuts 500 traditional roles for 350 ‘high-tech’ ones
May 22, 2017Manufacturing and Production, Research and Development, Sales and Marketing Novartis
Novartis has announced a restructure within the company which will lead to the transfer or loss of 500 traditional production …
Amgen hit by major safety blow on osteoporosis drug
May 22, 2017Research and Development, Sales and Marketing Amgen, Romosozumab, UCB SA
Amgen and UCB SA have been delivered a crushing blow in its attempt to have a drug for osteoporosis approved …
70 patients sue Pfizer over arthritis drug risks
May 22, 2017Sales and Marketing Pfizer, celebrex
Pfizer has been hit with a £3.5 million lawsuit by 70 Scottish patients who claim that the use of its …
AstraZeneca sells off rights to beta-blocker for $300 million
May 22, 2017Sales and Marketing AstraZeneca, Recordati, Seloken
AstraZeneca announced that it had sold the European rights to its drug, Seloken (metoprolol), to Italian pharmaceutical company Recordati. The …
No causal link between Viagra use and melanoma, study finds
May 19, 2017Medical Communications, Research and Development melanoma, viagra
Research from the NYU Langone Medical Center and its Perlmutter Cancer Center, based in New York City, has indicated that …
AbbVie suffers knock to Humira patent
May 19, 2017Medical Communications, Sales and Marketing AbbVie, Humira, patents
Humira is the largest selling pharmaceutical drug in the world. The treatment for rheumatoid arthritis brought in over $16 billion …
Top Ten most popular articles on Pharmafile.com this week
May 19, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing top ten
With every week we draw closer to the event everyone in the UK is talking about – the general election. …
Latest content
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
Danish medical cannabis use rises as regulator reports no new safety signals
